Procurement Summary
Country: Kazakhstan
Summary: Purchase of Medicines, Medicines, Medical Products in Accordance with Technical Specifications in Agreement with the Customer, Amt: 2091172.52
Deadline: 05 May 2026
Posting Date: 30 Apr 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 140458640
Document Ref. No.: 16917036-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 2091172.52
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Ranitidine - Capsules containing enteric-coated minimicrospheres, 150 mg, No. 10. Composition - One capsule contains the active substance - pancreatin 150 mg, with minimal enzymatic activity: amylase - 8000 Euro units. F., lipase - 10000 units Heb. F., proteases - 600 EUR units. F., excipients pellet core: macrogol 4000, pellet shell: cetyl alcohol, hypromellose phthalate, triethyl citrate, dimethicone 1000, capsule shell: gelatin, anhydrous iron (III) oxide (E 172), iron (III) oxide hydrated (E 172), iron (II, III) oxide (E 172), titanium dioxide (E 171), sodium lauryl sulfate. Quantity-15 packs | Midecamycin - Film-coated tablets 500 mg/125 mg, 875 mg/125 mg, One film-coated tablet contains active substances: amoxicillin (as amoxicillin trihydrate) 500 mg and clavulanic acid (as potassium clavulanate) 125 mg (for a dosage of 500 mg/125 mg) or amoxicillin (as amoxicillin trihydrate) 875 mg and clavulanic acid (as potassium clavulanate) 125 mg (for a dosage of 875 mg/125 mg). Excipients: colloidal silicon dioxide, crospovidone anhydrous, sodium carboxymethylcellulose, magnesium stearate, dried microcrystalline cellulose. film shell composition: hydroxypropyl cellulose, ethyl cellulose, polysorbate, triethyl citrate, titanium dioxide (E 171), talc. Film-coated tablets of white or almost white color, oblong, chamfered, engraved 875/12...
Documents
Tender Notice